Türkiye as a pharmerging market: Opportunities and challenges ahead
The future of the Turkish pharmaceutical industry depends on the implementation of cost-effective programs in public health care insurance schemes and...
Stay updated with breaking news from Security Institution. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The future of the Turkish pharmaceutical industry depends on the implementation of cost-effective programs in public health care insurance schemes and...
Ruling on the condition of plausible proof, the Ankara IP Court has clarified that an injunction can be granted in a way that prevents damages for both parties. This is especially crucial for cases in which the infringing product is put on the market without waiting for an expert report.
The Turkish government, swift in its response to repair the damage and rebuild the region impacted by last year's earthquakes, has allocated over TL 1...
Selin Sinem Erciyas, Zeynep Çağla Üstün, and Beste Turan of Gün and Partners explain a decision by the Turkish Civil Court for Intellectual and Industrial Property Rights that set an important precedent for the protection of pharmaceutical patent holders’ rights